Αρχική World News 5 Tips to Move Beyond the Bedside

5 Tips to Move Beyond the Bedside

Have you ever wondered how a nurse can expand on their bedside role to include other areas of interest or moving into different roles? While everyone has their own story, there are a few things that bridge many stories and that you can do to support your career journey. Maybe your goal is getting involved in research, working with a patient group, moving to a new specialty, or moving away from the bedside. These tips can help you reach your goal(s):

  • Identify your area(s) of interest. It might not be so clear right away and doing some of the other things on the list might help you better define your interests. It can be helpful to talk about things you’ve enjoyed about your job with a colleague – see what pops up through discussion. And know that these interests will change and evolve over time. It can also be helpful to occasionally, jot down things that make you appreciate the job you have now, as well as things you might think don’t work as well for your life. Looking back on these, you might start to get a clearer picture of areas that interest you.
  • Get involved! If you are asked to join a committee or workgroup, do it! Or volunteer for a committee in your organization. This is a great way to explore an interest but also to meet other people with a similar interest or to get to know other people in your organization that you might otherwise never meet.
  • Does your specialty area have a professional organization? Join in and get involved! Do they have a local chapter?- Even better – this is a great way to meet folks from your area who have similar interests.
  • Find a mentor (or two)! Is there someone doing your “dream job?” Reach out – meet for coffee and bring some questions to learn about their career path, what they like and don’t like, ask for ideas on how to get started.
  • Don’t be afraid to make a change! Many people become so focused on a particular goal/job/interest that they miss an interesting opportunity as they are speeding by. Check out different opportunities, attend talks on different specialty areas, and get to know nurses in parts of your organization.

When I graduated with my BSN in 1993, the Internet was not a household word, to say the least. But here I am years later, running a website and working with technology I could never have imagined at that time. I was always interested in patient education and looked for ways to engage in that interest – beginning with making bulletin boards on my inpatient unit. That led to joining a patient education committee, developing education materials for our unit, and eventually enrolling in a master’s program to be a Clinical Nurse Specialist. My career path made many turns along the way and ultimately brought me to OncoLink where my love of patient education introduced me to technology. There were many people who helped mentor and guide me along the way – most of them did not work in patient education or technology – but they provided a sounding board and levelheaded advice. I hope these tips can help you make the most of your career path!


Carolyn Vachani is an oncology advanced practice nurse and the Managing Editor at OncoLink. She has worked in many areas of oncology including BMT, clinical research, radiation therapy and staff development. She serves as the project leader in the development and maintenance of the OncoLife Survivorship Care Plan and has a strong interest in oncology survivorship care. She enjoys discussing just about any cancer topic, as well as gardening, cooking and, of course, her sons.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

10 Ways You Can Nurture A More Sustainable Garden

Sustainable gardening doesn’t have a firm, technical definition. It’s the concept of using sustainable gardening techniques that not only cause no harm to the...

Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics (‘GammaDelta’), has been given approval from the US Food and Drug Administration (FDA) to trial its unique T-cell...

Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant Chemotherapy

The ECOG-ACRIN EA1131 study hypothesised that invasive disease-free survival (iDFS) would not be inferior but improved in patients with basal subtype triple-negative breast cancer...

Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit [ESMO Virtual Plenary Press Release]

VP6-2021 - IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk,...

Breaking News: Supreme Court Upholds the Affordable Care Act

It’s a great day for cancer survivors. The Supreme Court of the United States (SCOTUS) upheld the Affordable Care Act (ACA), commonly known as...

How Does CAR T-Cell Therapy Work in Treating Cancer?

Craig A. Portell, MD, is an Associate Professor of Medicine at the University of Virginia and a member of the UVA Cancer Center in...